Literature DB >> 11747302

Role of Src kinase in diperoxovanadate-mediated activation of phospholipase D in endothelial cells.

N L Parinandi1, S Roy, S Shi, R J Cummings, A J Morris, J G Garcia, V Natarajan.   

Abstract

We have shown earlier that oxidant-induced activation of phospholipase D (PLD) in vascular endothelial cells (ECs) is regulated by protein tyrosine kinases. To further understand the regulation of oxidant-induced PLD activation, we investigated the role of Src kinase. Treatment of bovine pulmonary artery ECs (BPAECs) with a model oxidant, diperoxovanadate (DPV), at 5 microM concentration, for 30 min, stimulated PLD activity (four- to eightfold), which was attenuated by tyrosine kinase inhibitors and by Src kinase-specific inhibitors PP-1 and PP-2, in a dose- and time-dependent fashion. Furthermore, BPAECs exposed to DPV (5 microM) for 2 min showed activation of Src kinase as observed by increased tyrosine phosphorylation and autophosphorylation in Src immunoprecipitates, which was attenuated by PP-2. Src immunoprecipitates of cell lysates from control BPAECs exhibited PLD activity in cell-free preparations, which was Arf- and Rho-sensitive and was enhanced at 2 min of DPV (5 microM) treatment. Also, Western blots of Src immunoprecipitates of control cells revealed the presence of PLD(1) and PLD(2), suggesting the association of PLD with Src kinase under basal conditions. However, exposure of cells to DPV (5 microM) for 2 min enhanced the association of PLD(2) but not PLD(1) with Src. Western blotting of immunoprecipitates of PLD(1) and PLD(2) isoforms of control BPAECs revealed the presence of Src under basal conditions and exposure of cells to DPV (5 microM) for 2 min enhanced the association of PLD(2) with Src in PLD(2) immunoprecipitates. Transient expression of a dominant negative mutant of Src in BPAECs attenuated DPV- but not TPA-induced PLD activation. In cell-free preparations, Src did not phosphorylate either PLD(1) or PLD(2) compared to protein kinase Calpha or p38 mitogen-activated protein kinase. These data show for the first time a direct association of Src with PLD in ECs and regulation of PLD in intact cells. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747302     DOI: 10.1006/abbi.2001.2609

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide.

Authors:  Rishi B Patel; Sainath R Kotha; Lynn A Sauers; Smitha Malireddy; Travis O Gurney; Niladri N Gupta; Terry S Elton; Ulysses J Magalang; Clay B Marsh; Boyd E Haley; Narasimham L Parinandi
Journal:  Toxicol Mech Methods       Date:  2012-06       Impact factor: 2.987

2.  Phospholipase C-γ2 via p38 and ERK1/2 MAP kinase mediates diperoxovanadate-asparagine induced human platelet aggregation and sCD40L release.

Authors:  Ankita Misra; Smriti Srivastava; Seshadri Reddy Ankireddy; Nashreen S Islam; Tulika Chandra; Ashutosh Kumar; Manoj Kumar Barthwal; Madhu Dikshit
Journal:  Redox Rep       Date:  2013-07-23       Impact factor: 4.412

3.  Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.

Authors:  Rishi B Patel; Sainath R Kotha; Shariq I Sherwani; Sean M Sliman; Travis O Gurney; Brooke Loar; Susan O'Connor Butler; Andrew J Morris; Clay B Marsh; Narasimham L Parinandi
Journal:  Int J Toxicol       Date:  2010-12-03       Impact factor: 2.032

4.  Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells.

Authors:  Jordan D Secor; Sainath R Kotha; Travis O Gurney; Rishi B Patel; Nicholas R Kefauver; Niladri Gupta; Andrew J Morris; Boyd E Haley; Narasimham L Parinandi
Journal:  Int J Toxicol       Date:  2011-10-12       Impact factor: 2.032

Review 5.  Phospholipase D/phosphatidic acid signal transduction: role and physiological significance in lung.

Authors:  Rhett Cummings; Narasimham Parinandi; Lixin Wang; Peter Usatyuk; Viswanathan Natarajan
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 6.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

7.  Activation of RBL-2H3 mast cells is dependent on tyrosine phosphorylation of phospholipase D2 by Fyn and Fgr.

Authors:  Wahn Soo Choi; Takaaki Hiragun; Jun Ho Lee; Young Mi Kim; Hyoung-Pyo Kim; Ahmed Chahdi; Erk Her; Jeung Whan Han; Michael A Beaven
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells.

Authors:  Peter V Usatyuk; Irina A Gorshkova; Donghong He; Yutong Zhao; Satish K Kalari; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

9.  Phosphatidic Acid Produced by RalA-activated PLD2 Stimulates Caveolae-mediated Endocytosis and Trafficking in Endothelial Cells.

Authors:  Ying Jiang; Maria S Sverdlov; Peter T Toth; Long Shuang Huang; Guangwei Du; Yiyao Liu; Viswanathan Natarajan; Richard D Minshall
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

10.  Phospholipase D signaling mediates reactive oxygen species-induced lung endothelial barrier dysfunction.

Authors:  Peter V Usatyuk; Sainath R Kotha; Narasimham L Parinandi; Viswanathan Natarajan
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.